{"database": "lobbying", "table": "lobbying_activities", "rows": [[3239451, "4ce76927-204f-448c-a300-059d2b1ba02d", "Q3", "THE LIAISON GROUP, LLC", 401104378, "NATIONAL CANNABIS ROUNDTABLE", 2024, "third_quarter", "CSP", "Engaging with Congress on issues surrounding packaging, labeling, and tracing of regulated cannabis products. Educating on difference between cannabis, synthetic substances, and synthetic intoxicants that mimic cannabinoids", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,White House Office", 65500, null, 0, 0, "2024-10-16T09:35:23-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3239451"], "units": {}, "query_ms": 10.403833002783358, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}